At Vifor Pharma Ltd Dr. Flühmann was in the field of anemia therapy acting as Global Brand Director for intravenous iron preparations defining global strategic product plans across all functions (medical, marketing, market research, regulatory, life cycle management, logistics) and ensuring the operational execution. In his current position at Vifor Pharma Ltd Dr. Flühmann is Global Lead Nanomedicines. His main interest is in the translational science namely the regulatory aspects of nanomedicines and their follow-on products as well as the specific aspects that need to be considered in evaluation selection and handling of nanomedicines in clinical practice. He is Steering Committee Member of the Non-Biological Complex Drugs Working Group hosted at Lygature a non for profit organization. The mission of the Non-Biological Complex Drugs Working Group is to work on appropriate and harmonized science-based approval and post-approval standards for Non-Biological Complex Drugs to ensure patient benefit and safety